[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 184.73.66.157. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
February 1993

Aseptic Meningitis and Intravenous Gammaglobulin Treatment-Reply

Author Affiliations

State University of New York Health Science Center at Brooklyn 450 Clarkson Ave Box 49 Brooklyn, NY 11203

Am J Dis Child. 1993;147(2):129-130. doi:10.1001/archpedi.1993.02160260019007
Abstract

In Reply.—We read with interest Dr Özsoylu's comments regarding our report. Our main purpose was to describe another case of aseptic meningitis following IVIG therapy to raise awareness among physicians of this complication. While additional cases continue to be reported by Watson et al and others,1 it seems that aseptic meningitis is still very uncommon and apparently benign. In general, we have been impressed with the rapidity of response and safety of IVIG therapy, and in addition have avoided bone marrow aspiration in most of our patients with ITP; we would feel compelled to do a bone marrow aspiration if we were to use steroid therapy. While the high-dose steroid regimen is reported by Özsoylu et al to have been tolerated very well, we remain concerned about the potential toxic effects of such therapy. A prospective randomized trial comparing these two treatments would be of interest.

First Page Preview View Large
First page PDF preview
First page PDF preview
×